Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Marijuana Labeling topic
No spam. Unsubscribe anytime.
Committee approves untimely PCS to label THC edibles and curb child-appealing packaging
Summary
An untimely PCS requiring THC-per-serving and per-package labeling and banning child-appealing shapes/animations for edible and drinkable marijuana products passed committee after sponsors cited pediatric ingestion cases; members discussed limits vs labeling and medical access for high-dose patients.
Chairman presented an untimely committee substitute addressing labeling and packaging for marijuana edibles and drinkables after the sponsor cited multiple pediatric ingestion incidents. The PCS would require packages to display total THC in the container and the THC-per-serving amount, and would ban products shaped like animated characters or otherwise designed to appeal to children.
The sponsor cited recent emergency cases involving toddlers and young children who ingested gummies and experienced serious reactions and hospitalizations. "It's happening," the chairman said, summarizing EMS and pediatric ICU cases involving children who consumed high-THC gummies. Representative Marty, while supporting child-safety goals, warned that many medical users rely on high-dose products (100 mg to 1,000 mg) and urged the industry and DHS to work on tougher packaging, flavorless formulations and limits that protect children without cutting off medical access.
Members discussed whether labeling alone would address illicit counterfeit products that mimic snack packaging; the sponsor said illegal counterfeit products are already illegal and the PCS focuses on legal products. Representative Roe asked whether the PCS limits per-package potency or only improves labeling; sponsors clarified the PCS as written specifies labeling and bans child-appealing shapes but does not impose a per-serving milligram cap in this draft.
The committee voted to report the PCS as a do-pass, 11 yeas and 1 nay. Sponsors said they would continue work with DHS and the industry to refine packaging and potency approaches before floor debate.
